Corporate Finance

Doughy conquered Los Angeles' ultra-premium grocery scene. Now, armed with $6.1 million and CPG heavyweights, it's betting middle America is ready for clean indulgence.

By tapping into 1,800 enterprise technology leaders, a new $32M micro-fund is rewriting the seed investing playbook for the generative AI era.

As the electric grid buckles under new demand, a $17 million investment in Switched Source highlights the urgent pivot to fast-deploying non-wires alternatives.

Mistlabs just raised $26 million to turn AI from a passive chatbot into an active mediator. But can its new wearable survive the Apple platform squeeze?

CrowdStrike’s latest battle with an offshore LLC highlights the hidden dangers of mini-tender offers and the regulatory gaps threatening retail investors.

As AI data centers strain the global grid, Alsym Energy's non-flammable sodium-ion batteries offer a radical, passive-cooling solution to power the future.

London-based IMMIX is bringing high-frequency trading discipline to non-USD stablecoins, raising $3.5M to build the invisible rails of global finance.

As multinational enterprises abandon slow wire transfers, Jeeves secures $110 million to scale its stablecoin-native corporate banking platform globally.

Corridor’s $25M launch reveals how autonomous AI agents are dismantling the legacy broker model to bring enterprise-level healthcare savings to Main Street.

Siguler Guff's record $3 billion close highlights a massive structural shift as investors abandon over-leveraged mega-caps for founder-owned lower middle-market firms.

With a $205 million mega-round, EnduroSat is bringing drone-like serial production to satellites, scaling transatlantic defense, and slashing data costs.

With over $100M in new capital, Delos Data unveils an architecture for the always-on demands of agentic AI, tackling the critical network bottleneck.

Biodexa nets $2.3M in a complex warrant deal, buying runway for its cancer and diabetes drugs at the steep price of massive potential shareholder dilution.

With GPUs wasting billions sitting idle, Cornelis and Qualcomm are betting $205M on an 'active' network fabric to break vendor lock-in and reshape AI infrastructure.

With a $1M funding round and a stunning 4,000-store rollout, Wizard Wellness is rewriting the startup playbook with its 'skincare for your nose' concept.

Frazier Life Sciences just closed a $1.1B+ oversubscribed fund. This isn't just another raise; it's a masterclass in navigating biotech volatility.

As Stewards Inc. moves from the OTC markets to Nasdaq, its journey reflects the mainstreaming of alternative finance and poses key questions for investors.

In a volatile climate, Apogem Capital's oversubscribed fund highlights institutional confidence in a niche strategy targeting private equity's resilient heartland.

While most crypto projects sell a vision, Remittix is building a live financial ecosystem—and it's already processing millions before its token even lists.

As giants like BlackRock pour billions into Bitcoin, a shadowy world of presales promises 100x returns. But what happens when the hype is built on an illusion?